CYBNSMALL

Cybin Inc.

HealthcareBiotechnology
$6.09
$0.00(+2.87%)
52W$5.50
$9.83
Updated May 7, 12:00 AM
RSI35
RS Rating28/99
Beta1.52
Volatility70%
F-Score3/9
Mkt Cap$304M
WEAKENING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

WEAKENING

Cybin Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 28), showing significant lag compared to the market leaders. Earnings contraction of 8% provides fundamental context to the price action. Investors should exercise caution due to high volatility (70% annualized), which requires wider risk management.

Relative Strength
28
out of 99
Lagging
Trend Score
1/4
Minervini Criteria
WEAKENING
Risk (Beta)
1.52
vs S&P 500
HIGH BETA
52W Position
14%
from 52W low
Near Low
Trend & Momentum Analysis

Trend Template (Minervini)

WEAKENING1/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$7.05
50 SMA > 100 SMA$6.61
100 SMA > 150 SMA$6.77
150 SMA > 200 SMA$6.99

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$6.81-10.60%BELOW
50 SMA$7.05-13.59%BELOW
100 SMA$6.61-7.88%BELOW
150 SMA$6.77-10.09%BELOW
200 SMA$6.99-12.90%BELOW

Price Performance

1D+2.9%
1W
1M
3M+1.8%
6M+0.3%
YTD-26.4%
1Y+0.2%
3Y-20.5%
52-Week Trading Range14% from low
$6.09
52W Low$5.50
52W High$9.83

Technical Indicators

RSI (14)BEARISH
35.5
305070
VCP ScoreCOOL
2/10
Base depth: 59.4%

Risk Profile

Beta
1.52
52W Vol
70%
ATR
$0.61
Max DD (1Y)
-39%

Volume Analysis

Today
292.4K
50D Avg
292.4K
Vol Ratio
1.00x
Liquidity
ILLIQUID

Earnings Momentum

Q2'25-5541%
$-2.86
Q3'25-121%
$-0.53
Q4'25-747%
$-1.44
Q1'26-817%
$-1.10
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:-9.21%

Stock Price CAGR

10 Years:-44.63%
5 Years:-37.79%
3 Years:-20.54%
1 Year:+0.16%

Return on Equity

10Y Avg:-350.8%
5Y Avg:-504.6%
3Y Avg:-44.8%
Last Year:-81.0%

Key Metrics

Market Cap$304M
Gross Margin
Net Margin
Piotroski F-Score3/9

Frequently Asked Questions

Is CYBN in an uptrend right now?

CYBN has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.

Is CYBN overbought or oversold?

CYBN's RSI (14) is 35. The stock is in neutral territory, neither overbought nor oversold.

Is CYBN outperforming the market?

CYBN has a Relative Strength (RS) Rating of 28 out of 99. CYBN is currently lagging the broader market.

Where is CYBN in its 52-week range?

CYBN is trading at $6.09, which is 62% of its 52-week high ($9.83) and 14% above its 52-week low ($5.50).

How volatile is CYBN?

CYBN has a Beta of 1.52 and 52-week volatility of 70%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.